At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
The actual location of this job is in Stein, AG, Switzerland. Relocation assistance is available for eligible candidates and their families, if needed. Be part of an exciting growth project where you’ll contribute to set up
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
We are looking for a DP Lead parenteral Iron, to join our team in Zurich or St. Gallen, Switzerland. As part of the Integrated Product Team Iron & Small Molecules within Technical Operations, you will be
About This Role: As the Lead Value and Access for Switzerland and Austria, you will play a pivotal role in designing and implementing strategies to maximize the value recognition of our drug portfolio among payors. You
Global Medical Director, Evidence Generation Lead About This Role: As the Global Medical Director, Evidence Generation Lead, you will play a pivotal role in advancing data generation initiatives for Dravet Syndrome therapeutic area. This position resides
About This Role: The Global Launch and Commercial Operations Lead is a senior individual contributor accountable for the end‑to‑end governance, readiness, and execution excellence of Biogen’s global commercial launch of zorevunersen — a potential first-in-class disease-modifying
Sentec is a Swiss-American medical device company specializing in respiratory care. Since its founding in 1999 the company utilizes a deep-tech approach that is founded on advanced science and avant-garde technologies for respiratory patients across care
The actual location of this job is in Stein, AG, Switzerland. Relocation assistance is available for eligible candidates and their families, if needed. Join Lonza AG as a (Senior) QA Expert Compliance, partnering with senior stakeholders
The Senior Laboratory Specialist, Tech Ops researches and develops new medicines for unmet medical needs through innovative medical science from inception, through clinical trials to commercialization. Assesses, monitors and ensures products meet clinical safety standards. Conducts
Company Description At Sobi, we believe diversity drives innovation and inclusion creates stronger teams. We are committed to building a workplace where everyone feels valued and empowered to contribute. If this role excites you but you’re
Expected Travel: None Requisition ID: 13863 About Teleflex Incorporated As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people’s lives. Through our vision to become
Company Description At Sobi, we believe diversity drives innovation and inclusion creates stronger teams. We are committed to building a workplace where everyone feels valued and empowered to contribute. If this role excites you but you’re
Salary Range:CHF93,800.00 - CHF174,200.00 BandLevel 4 Job Description Summary#LI-Hybrid Location: Basel Internal Title: Principal Scientist I Laboratory Excellence and Operation (LEO) is the key global resource for Line functions (LF) and BR Clinical Trial Teams for
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Veeam is the Data and AI Trust Company, specializing in helping organizations ensure their data and AI are fully understood, secured, and resilient to enable the acceleration of safe AI at scale. As the market leader